New guideline for Electroconvulsive Treatment has been published in Norway

05

Jul 2017

Electroconvulsive Treatment (ECT) is a well-established treatment with good results in severe mental disorders. Due to the danger of memory problems, strict requirements are imposed and the patient's written consent is initially required. The National Guideline states that the right to information and participation are basic patient rights that are central to the use of ECT, based on patient informed consent.

The guideline deals with the use of ECT in a number of mental disorders. In essence, other therapies will be considered as first choice and ECT will only be recommended exceptionally before other documented treatment measures. This is particularly true where rapid effects are desirable and which can enable the patient to use other treatment in the follow-up.

There have been a number of recommendations related to standards that should be established, including equipment, expertise and follow-up of treatment. The working group has been composed of professionals, researchers and user representatives.

Access the guideline in Norwegian here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

23

Feb 2022

On January 24, 2022, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than March 01, 2022. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added medical biochemistry, medical microbiology, immunology and transfusiology, and clinical pharmacology areas.

Read more

02

Feb 2022

The "New Method" is currently developing criteria for which methods other than drugs shall be prioritized for assessment within the framework at the national or local levels. On January 17, 2022, the project status was presented at the Ordering Forum for "New Method." It was reported that the project would require more resources and time than initially thought.

Read more

03

Dec 2021

On November 23, 2021, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than January 01, 2021. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty new codes were added in medical biochemistry, immunology and transfusiology, and clinical pharmacology areas.

Read more

29

Oct 2021

On September 27, 2021, the Decision Forum for "New Methods" decided not to introduce bronchial thermoplasty as a routine treatment of patients with severe asthma. The method should only be used within clinical trials.

Read more

26

Oct 2021

On September 23, 2021, the Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system and associated tariffs for state and private laboratories to be implemented no later than November 01, 2021. NLK system has been used for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings since 2018. Thirty-nine new codes were added in medical biochemistry, clinical pharmacology, and medical microbiology areas.

Read more